Washington DC – Friends of Cancer Research (Friends) joins the nation in mourning the loss of former Democratic Representative John Dingell of Michigan. “For decades, the country counted on the veracity and leadership of John during some of our country’s most pivotal moments,” said Ellen Sigal, Chair, and Marlene Malek, Vice Chair, of Friends. “While…
Washington, DC – The Lung Cancer Master Protocol (Lung-MAP), the first precision medicine trial in lung cancer supported by the National Cancer Institute (NCI), part of the National Institutes of Health, is undergoing a major expansion to include patients with all non-small cell lung cancers – which make up about 85 percent of all lung…
Friends Welcomes Margaret Anderson, Edward J. Benz Jr, and Elizabeth Thompson January 17, 2019 – Washington, DC – Friends of Cancer Research (Friends) is pleased to announce the additions of Margaret Anderson, Dr. Edward J. Benz Jr., and Elizabeth Thompson to its Board of Directors. The new members bring a wealth of experience and expertise…
Friends of Cancer Research Applauds this Appointment and Thanks Dr. Rachel Sherman for Her Incredible Service December 17, 2018 – Washington, DC – Today, the U.S. Food and Drug Administration (FDA) announced that Dr. Amy Abernethy will replace Dr. Rachel Sherman as Principal Deputy Commissioner of Food and Drugs. Friends of Cancer Research (Friends) applauds…
WASHINGTON, DC – The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute’s (NCI) recent revision of its clinical trial protocol template to broaden eligibility criteria for cancer clinical trials. The protocol template was expanded to help increase the opportunity for participation in NCI-funded clinical trials…
Results to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting November 6, 2018 – Washington, DC – Friends of Cancer Research (Friends) is pleased to announce that the results of Phase I of the tumor mutational burden (TMB) Harmonization Project will be presented as a late-breaking abstract at the Society…
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds Senators Orrin Hatch (R-UT) and Michael Bennet (D-CO) for responding to a recently identified public health issue and swiftly proposing a solution to an issue impacting patients and their physicians…
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization team finalizes data collected from the Phase I in silico analysis. “Recent data shows a role for TMB in identifying patients more likely…
August 9, 2018 – WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the Food and Drug Administration (FDA) recommended language for five guidance documents on ways to broaden eligibility criteria for cancer clinical trials. The recommendations are part of an ASCO and Friends…
New Data Supporting Use of Real-World Evidence Presented with Six Data Partners as well as FDA July 10, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) released the results of a unique pilot project at its event, The Future Use of Real-World Evidence. Data was compiled from six data partners regarding patients…
